Rapidly advancing treatment options and emerging technologies continue to contribute to the advancement of the field of precision oncology.
Universitätsspital Zürich, Rämistrasse 100, 8091 Zürich
Grosser Hörsaal PATH / D22
02.04.2025
09:00 - 17:00
tbd
Kostenlos
| 09:00 | Welcome Markus G. Manz, University Hospital Zurich |
| 09:10 | Session 1: Definition of clinical needs for Precision Oncology Davide Rossi |
| 09:15 | Pediatric Cancers Nastassja Scheidegger, Children’s Hospital Zurich (tbc) |
| 09:45 | INTeRCePT (Lymphoma) Thorsten Zenz, University Hospital Zurich |
| 10:15 | CLL George Follows, Cambridge University (tbc) |
| 10:45 | Break |
| 11:10 | Session 2: Data Science in Precision Oncology Markus Rudin (tbc), Björn Menze |
| 11:15 | Towards quantitative bioimage analysis at scale Virginie Uhlmann, University of Zurich |
| 11:45 | (Low) noise-resistance of multi-omics survival models in cancer Valentina Boeva, ETH Zurich |
| 12:15 | Research assessment Wolfgang Huber, EMBL Heidelberg |
| 12:45 | Lunch Break and Posters |
| 13:40 | Session 3: Single Cell Technology applied to Precision Oncology Problems Burkhard Becher , Chiara Magnani |
| 13:45 | Lymphoma Satu Mustjoki, University of Helsinki, Finland (tbc) |
| 14:15 | AML Alexandre Theocharides, University Hospital Zurich |
| 14:45 | scRNAseq and spatial transcriptomes Andreas Moor, ETH Zurich |
| 15:15 | Break |
| 15:40 | Session 4: p53 in Cancer Thorsten Zenz, Steffen Böttcher |
| 15:45 | Deterministic evololution in p53 mutant cancer Kasper Karlson, Karolinska Insitute, Stockholm |
| 16:15 | p53-based cancer therapy: strategies and challenges Moshe Oren, Weizmann Institute of Science, Israel |
| 16:45 | Wrap-up Thorsten Zenz, University Hospital Zurich |
Bitte melden Sie sich bis zum 02.04.2025 an.
Please register by April 2, 2025.
